ZNF217 and cancer: Amplification at the ZNF217 locus has been previously reviewed [8] and linked to poor prognosis in several cancers [7, 9-11, 53]; however other authors have failed to make this link [69-72], likely due to differences in probes and cutoff levels used for amplification evaluation.